Market Research Logo

Human Papillomavirus Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Human Papillomavirus Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, “Human Papillomavirus Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 provides an overview of Human Papillomavirus Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Human Papillomavirus Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Human Papillomavirus Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Human Papillomavirus Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Human Papillomavirus Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Human Papillomavirus Diagnostic Tests Overview
3 Products under Development
3.1 Human Papillomavirus Diagnostic Tests - Pipeline Products by Stage of Development
3.2 Human Papillomavirus Diagnostic Tests - Pipeline Products by Territory
3.3 Human Papillomavirus Diagnostic Tests - Pipeline Products by Regulatory Path
3.4 Human Papillomavirus Diagnostic Tests - Pipeline Products by Estimated Approval Date
3.5 Human Papillomavirus Diagnostic Tests - Ongoing Clinical Trials
4 Human Papillomavirus Diagnostic Tests - Pipeline Products under Development by Companies
4.1 Human Papillomavirus Diagnostic Tests Companies - Pipeline Products by Stage of Development
4.2 Human Papillomavirus Diagnostic Tests - Pipeline Products by Stage of Development
5 Human Papillomavirus Diagnostic Tests Companies and Product Overview
5.1 AutoGenomics, Inc. Company Overview
5.1.1 AutoGenomics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.2 Beckman Coulter, Inc. Company Overview
5.2.1 Beckman Coulter, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.3 Becton, Dickinson and Company Company Overview
5.3.1 Becton, Dickinson and Company Pipeline Products & Ongoing Clinical Trials Overview
5.4 Biocartis SA Company Overview
5.4.1 Biocartis SA Pipeline Products & Ongoing Clinical Trials Overview
5.5 Biomagnetics Diagnostics Corporation (Inactive) Company Overview
5.5.1 Biomagnetics Diagnostics Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.6 Bioorganic Research and Services S.A. Company Overview
5.6.1 Bioorganic Research and Services S.A. Pipeline Products & Ongoing Clinical Trials Overview
5.7 Bio-Techne Corp Company Overview
5.7.1 Bio-Techne Corp Pipeline Products & Ongoing Clinical Trials Overview
5.8 Cepheid Company Overview
5.8.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview
5.9 China Medical Technologies, Inc. Company Overview
5.9.1 China Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.10 Chronix Biomedical, Inc. Company Overview
5.10.1 Chronix Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.11 Co-Diagnostics HBDC, Inc. Company Overview
5.11.1 Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.12 Enigma Diagnostics Limited Company Overview
5.12.1 Enigma Diagnostics Limited Pipeline Products & Ongoing Clinical Trials Overview
5.13 Enzo Life Sciences, Inc. Company Overview
5.13.1 Enzo Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.14 Genera Biosystems Limited Company Overview
5.14.1 Genera Biosystems Limited Pipeline Products & Ongoing Clinical Trials Overview
5.15 German Cancer Research Center Company Overview
5.15.1 German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview
5.16 Goodgene Inc Company Overview
5.16.1 Goodgene Inc Pipeline Products & Ongoing Clinical Trials Overview
5.17 Great Basin Corporation Company Overview
5.17.1 Great Basin Corporation Pipeline Products & Ongoing Clinical Trials Overview
5.18 HEALTH BioMed Co., Ltd. Company Overview
5.18.1 HEALTH BioMed Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.19 Homepoint Testing Company Overview
5.19.1 Homepoint Testing Pipeline Products & Ongoing Clinical Trials Overview
5.20 IncellDx, Inc. Company Overview
5.20.1 IncellDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.21 KogeneBiotech Co Ltd Company Overview
5.21.1 KogeneBiotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.22 MEDITE Cancer Diagnostics, Inc. Company Overview
5.22.1 MEDITE Cancer Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.23 MedNostic Technologies, LLC Company Overview
5.23.1 MedNostic Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.24 Molbio Diagnostics Pvt. Ltd. Company Overview
5.24.1 Molbio Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.25 New Mexico Cancer Care Alliance Company Overview
5.25.1 New Mexico Cancer Care Alliance Pipeline Products & Ongoing Clinical Trials Overview
5.26 Novacyt Company Overview
5.26.1 Novacyt Pipeline Products & Ongoing Clinical Trials Overview
5.27 OncoHealth Corporation Company Overview
5.27.1 OncoHealth Corporation Pipeline Products & Ongoing Clinical Trials Overview
5.28 Pathogenica, Inc. Company Overview
5.28.1 Pathogenica, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.29 Provista Diagnostics Inc. Company Overview
5.29.1 Provista Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.30 Quidel Corporation Company Overview
5.30.1 Quidel Corporation Pipeline Products & Ongoing Clinical Trials Overview
5.31 Rheonix, Inc. Company Overview
5.31.1 Rheonix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.32 Roche Diagnostics International Ltd. Company Overview
5.32.1 Roche Diagnostics International Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.33 Roche Molecular Systems, Inc. Company Overview
5.33.1 Roche Molecular Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.34 Sansure Biotech Inc Company Overview
5.34.1 Sansure Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
5.35 Seattle Children’s Research Institute Company Overview
5.35.1 Seattle Children’s Research Institute Pipeline Products & Ongoing Clinical Trials Overview
5.36 Seegene, Inc. Company Overview
5.36.1 Seegene, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.37 Sequenom, Inc. Company Overview
5.37.1 Sequenom, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.38 The Feinstein Institute for Medical Research Company Overview
5.38.1 The Feinstein Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview
5.39 The University of Queensland Company Overview
5.39.1 The University of Queensland Pipeline Products & Ongoing Clinical Trials Overview
5.40 TrovaGene, Inc. Company Overview
5.40.1 TrovaGene, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.41 University of Texas at Austin Company Overview
5.41.1 University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview
5.42 ValiRx Plc Company Overview
5.42.1 ValiRx Plc Pipeline Products & Ongoing Clinical Trials Overview
5.43 Yale University Company Overview
5.43.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview
6 Human Papillomavirus Diagnostic Tests - Recent Developments
6.1 Sep 27, 2016: ValiRx: Half Yearly Report for the Period Ended 30 June 2016
6.2 Sep 13, 2016: ValiRx: Quarterly Update On Clinical Developments
6.3 Sep 06, 2016: BD Submits Pre-Market Approval Application to FDA for BD Onclarity HPV Test
6.4 Sep 02, 2016: Danaher to Acquire Cepheid
6.5 Aug 04, 2016: Trovagene Reports Second Quarter 2016 Financial Results and Accomplishments
6.6 Aug 04, 2016: BD Announces Results For 2016 Third Fiscal Quarter
6.7 Jul 28, 2016: QIAGEN Reports Results for Second Quarter of 2016; Increased Commitment to Return $300 Million of Capital to Shareholders by End-2017
6.8 Jul 28, 2016: BD Names R. Andrew Eckert To Board Of Directors
6.9 Jul 28, 2016: Cepheid Reports Second Quarter 2016 Results
6.10 Jul 27, 2016: Hologic Announces Financial Results for Third Quarter of Fiscal 2016
6.11 Jul 27, 2016: Quidel Reports Second Quarter 2016 Financial Results
6.12 Jul 11, 2016: David Coorey Joins Agena Bioscience to Lead Europe, Middle East, and Africa Business
6.13 Jul 06, 2016: Bio-Techne Acquires Advanced Cell Diagnostics
6.14 Jul 04, 2016: Exiqon - Nomination of candidates for the supervisory board
6.15 Jun 21, 2016: Genera Biosystems provides update on PapType HPV test
6.16 May 25, 2016: MEDITE Cancer Diagnostics Raises USD0.15 Million in Venture Financing
6.17 May 10, 2016: Trovagene Announces First Quarter 2016 Financial Results
6.18 May 09, 2016: Novacyt Enters into Clinical Trial Agreement with St Stephen’s AIDS Trust
6.19 Feb 15, 2016: Novacyt to Collaborate to Validate HPV Testing with NOVAprep Technology
6.20 Feb 03, 2016: NEUMANN Diagnostics’ automated cervical cancer test achieves exceptional accuracy
6.21 Feb 01, 2016: Updated cervical cancer screening guidelines from leading ob-gyn society support expanded use of cobas HPV Test for primary screening
6.22 Jan 04, 2016: Seegene’s HPV DNA assay proves its excellent performance in WHO global HPV LabNet study
6.23 Nov 12, 2015: New Modeling Analysis Shows Screening for Cervical Cancer with Pap+HPV Together Could Provide Better Clinical and Economic Outcomes than Screening with HPV Alone
6.24 Oct 12, 2015: Roche Wins the first HPV Primary Screening Tender in Europe
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Human Papillomavirus Diagnostic Tests - Pipeline Products by Stage of Development
Table 2: Human Papillomavirus Diagnostic Tests - Pipeline Products by Territory
Table 3: Human Papillomavirus Diagnostic Tests - Pipeline Products by Regulatory Path
Table 4: Human Papillomavirus Diagnostic Tests - Pipeline Products by Estimated Approval Date
Table 5: Human Papillomavirus Diagnostic Tests - Ongoing Clinical Trials
Table 6: HPV Companies - Pipeline Products by Stage of Development
Table 7: Human Papillomavirus Diagnostic Tests - Pipeline Products by Stage of Development
Table 8: AutoGenomics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 9: INFINITI HPV Genotyping Assay - Product Status
Table 10: INFINITI HPV Genotyping Assay - Product Description
Table 11: INFINITI HPV-HR Quad Assay - Product Status
Table 12: INFINITI HPV-HR Quad Assay - Product Description
Table 13: Beckman Coulter, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 14: DxN VERIS HPV Assay - Product Status
Table 15: DxN VERIS HPV Assay - Product Description
Table 16: Becton, Dickinson and Company Pipeline Products & Ongoing Clinical Trials Overview
Table 17: BD Max HPV Assay - Product Status
Table 18: BD Max HPV Assay - Product Description
Table 19: BD Onclarity HPV Assay - Product Status
Table 20: BD Onclarity HPV Assay - Product Description
Table 21: Biocartis SA Pipeline Products & Ongoing Clinical Trials Overview
Table 22: Idylla HPV Test - Head & Neck Cancer - Product Status
Table 23: Idylla HPV Test - Head & Neck Cancer - Product Description
Table 24: Biomagnetics Diagnostics Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Diagnostic Test - HPV - Product Status
Table 26: Diagnostic Test - HPV - Product Description
Table 27: Bioorganic Research and Services S.A. Pipeline Products & Ongoing Clinical Trials Overview
Table 28: BNTIVD002 Assay - HPV Immune Response Monitoring - Product Status
Table 29: BNTIVD002 Assay - HPV Immune Response Monitoring - Product Description
Table 30: Bio-Techne Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 31: RNAscope HPV Assay - Cervical Cancer - Product Status
Table 32: RNAscope HPV Assay - Cervical Cancer - Product Description
Table 33: RNAscope HPV Assay - Head and Neck Cancer - Product Status
Table 34: RNAscope HPV Assay - Head and Neck Cancer - Product Description
Table 35: Cepheid Pipeline Products & Ongoing Clinical Trials Overview
Table 36: GeneXpert - Xpert HPV CLIA Waived - Product Status
Table 37: GeneXpert - Xpert HPV CLIA Waived - Product Description
Table 38: China Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 39: SPR Based DNA Chip - Sexually Transmitted Diseases - Product Status
Table 40: SPR Based DNA Chip - Sexually Transmitted Diseases - Product Description
Table 41: Chronix Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 42: Companion Diagnostic Test - HPV - Product Status
Table 43: Companion Diagnostic Test - HPV - Product Description
Table 44: Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 45: Diagnostic Test - HPV - Product Status
Table 46: Diagnostic Test - HPV - Product Description
Table 47: Enigma Diagnostics Limited Pipeline Products & Ongoing Clinical Trials Overview
Table 48: Enigma MiniLab - HPV - Product Status
Table 49: Enigma MiniLab - HPV - Product Description
Table 50: Enzo Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 51: Next-Generation Branched DNA Assay - HPV - Product Status
Table 52: Next-Generation Branched DNA Assay - HPV - Product Description
Table 53: Genera Biosystems Limited Pipeline Products & Ongoing Clinical Trials Overview
Table 54: PapType - Product Status
Table 55: PapType - Product Description
Table 56: PapType SP - Product Status
Table 57: PapType SP - Product Description
Table 58: German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview
Table 59: HPV Genotyping Assay - Cervical Cancer - Product Status
Table 60: HPV Genotyping Assay - Cervical Cancer - Product Description
Table 61: Goodgene Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 62: GG HPV DNA Genotyping Chip - Product Status
Table 63: GG HPV DNA Genotyping Chip - Product Description
Table 64: Great Basin Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 65: Diagnostic Test - Human Papilloma Virus - Product Status
Table 66: Diagnostic Test - Human Papilloma Virus - Product Description
Table 67: HEALTH BioMed Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 68: 3500Dx Genetic Analyzer - SureX HPV 25 Genotyping Assay Kit - Product Status
Table 69: 3500Dx Genetic Analyzer - SureX HPV 25 Genotyping Assay Kit - Product Description
Table 70: Homepoint Testing Pipeline Products & Ongoing Clinical Trials Overview
Table 71: HPV-Inform - Product Status
Table 72: HPV-Inform - Product Description
Table 73: IncellDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 74: HPV OncoTect mRNA - Product Status
Table 75: HPV OncoTect mRNA - Product Description
Table 76: KogeneBiotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 77: SuperFast HPV Low risk 5 Multiplex Real-time PCR Kit - Product Status
Table 78: SuperFast HPV Low risk 5 Multiplex Real-time PCR Kit - Product Description
Table 79: MEDITE Cancer Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 80: Diagnostic Assay - HPV - Product Status
Table 81: Diagnostic Assay - HPV - Product Description
Table 82: MedNostic Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 83: MedNetic HPV Immunoassay - Product Status
Table 84: MedNetic HPV Immunoassay - Product Description
Table 85: Molbio Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 86: Truenat HPV - Product Status
Table 87: Truenat HPV - Product Description
Table 88: New Mexico Cancer Care Alliance Pipeline Products & Ongoing Clinical Trials Overview
Table 89: Exosome Test - HPV Positive Oropharyngeal Squamous Cell Carcinoma - Product Status
Table 90: Exosome Test - HPV Positive Oropharyngeal Squamous Cell Carcinoma - Product Description
Table 91: New Mexico Cancer Care Alliance - Ongoing Clinical Trials Overview
Table 92: Exosome Test - HPV Positive Oropharyngeal Squamous Cell Carcinoma - An Observational, Single-Institution Pilot/Feasibility Study of Exosome Testing as a Screening Modality for Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma
Table 93: Novacyt Pipeline Products & Ongoing Clinical Trials Overview
Table 94: Genesig Kit - Human Papillomavirus 16 - Product Status
Table 95: Genesig Kit - Human Papillomavirus 16 - Product Description
Table 96: OncoHealth Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 97: HPV E6 Analyte Specific Reagents Kit - Product Status
Table 98: HPV E6 Analyte Specific Reagents Kit - Product Description
Table 99: HPV E7 Analyte Specific Reagents Kit - Product Status
Table 100: HPV E7 Analyte Specific Reagents Kit - Product Description
Table 101: Pathogenica, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 102: HPV Strain Genotyping Test - Product Status
Table 103: HPV Strain Genotyping Test - Product Description
Table 104: Provista Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 105: Blood-Based Diagnostic Test - Cervical Cancer - Product Status
Table 106: Blood-Based Diagnostic Test - Cervical Cancer - Product Description
Table 107: Blood-Based Diagnostic Test - Oropharyngeal Cancer - Product Status
Table 108: Blood-Based Diagnostic Test - Oropharyngeal Cancer - Product Description
Table 109: Quidel Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 110: IsoAmp Assay - HPV - Product Status
Table 111: IsoAmp Assay - HPV - Product Description
Table 112: Rheonix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 113: Rheonix CARD HPV Assay - Product Status
Table 114: Rheonix CARD HPV Assay - Product Description
Table 115: Roche Diagnostics International Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 116: Amplicor HPV Kit - Product Status
Table 117: Amplicor HPV Kit - Product Description
Table 118: Cobas 6800 System - HPV Assay - Product Status
Table 119: Cobas 6800 System - HPV Assay - Product Description
Table 120: Cobas 8800 System - HPV Assay - Product Status
Table 121: Cobas 8800 System - HPV Assay - Product Description
Table 122: Roche Molecular Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 123: LINEAR ARRAY HPV Genotyping Test - Product Status
Table 124: LINEAR ARRAY HPV Genotyping Test - Product Description
Table 125: Sansure Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 126: 15 High-risk Human Papillomavirus DNA Fluorescence Diagnostic Kit - Product Status
Table 127: 15 High-risk Human Papillomavirus DNA Fluorescence Diagnostic Kit - Product Description
Table 128: 15 High-risk Human Papillomavirus DNA Genotyping Diagnostic Kit - Product Status
Table 129: 15 High-risk Human Papillomavirus DNA Genotyping Diagnostic Kit - Product Description
Table 130: Seattle Children’s Research Institute Pipeline Products & Ongoing Clinical Trials Overview
Table 131: Diagnostic Test - High Risk HPV - Product Status
Table 132: Diagnostic Test - High Risk HPV - Product Description
Table 133: Seegene, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 134: Anyplex II HPV HR - Product Status
Table 135: Anyplex II HPV HR - Product Description
Table 136: Sequenom, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 137: AttoSense HPV Test - Product Status
Table 138: AttoSense HPV Test - Product Description
Table 139: AttoSense HPV-G Test - Product Status
Table 140: AttoSense HPV-G Test - Product Description
Table 141: AttoSense HPV-Q Test - Product Status
Table 142: AttoSense HPV-Q Test - Product Description
Table 143: The Feinstein Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview
Table 144: Cervical HPV Staining Kit - Product Status
Table 145: Cervical HPV Staining Kit - Product Description
Table 146: The University of Queensland Pipeline Products & Ongoing Clinical Trials Overview
Table 147: Diagnostic Test - HPV Linked Head and Neck Cancer - Product Status
Table 148: Diagnostic Test - HPV Linked Head and Neck Cancer - Product Description
Table 149: TrovaGene, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 150: HPV Diagnostic Test - Men - Product Status
Table 151: HPV Diagnostic Test - Men - Product Description
Table 152: University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview
Table 153: Personalized Genomic Test - Cervical Cancer - Product Status
Table 154: Personalized Genomic Test - Cervical Cancer - Product Description
Table 155: ValiRx Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 156: Diagnostic Test - HPV - Product Status
Table 157: Diagnostic Test - HPV - Product Description
Table 158: Yale University Pipeline Products & Ongoing Clinical Trials Overview
Table 159: Diagnostic Assay - Cervical Cancer - Product Status
Table 160: Diagnostic Assay - Cervical Cancer - Product Description
Table 161: Glossary
1.2 List of Figures
Figure 1: Human Papillomavirus Diagnostic Tests - Pipeline Products by Stage of Development
Figure 2: Human Papillomavirus Diagnostic Tests - Pipeline Products by Territory
Figure 3: Human Papillomavirus Diagnostic Tests - Pipeline Products by Regulatory Path
Figure 4: Human Papillomavirus Diagnostic Tests - Pipeline Products by Estimated Approval Date
Figure 5: Human Papillomavirus Diagnostic Tests - Ongoing Clinical Trials

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report